AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
RadiopharmaceuticalsNuclear MedicineTechnetiumRadioisotopesForecastingRadiochemistryGallium RadioisotopesRadionuclide ImagingRheniumTinTechnetium CompoundsPoloniumOrganotechnetium CompoundsRadionuclide GeneratorsPentetic AcidIsotope LabelingRadiation DosageMercury RadioisotopesCopper RadioisotopesTissue DistributionSamariumWeatherWhole-Body CountingRadiometryIndium RadioisotopesRadioactivityRadiation ProtectionMinicomputersIodine RadioisotopesThiosemicarbazonesPositron-Emission TomographyOrganometallic CompoundsIndiumSodium Pertechnetate Tc 99mAstatineTechnetium Tc 99m LidofeninRelative Biological EffectivenessClimateRadioactive TracersTechnetium Tc 99m MedronateBody BurdenAlpha ParticlesRadiumMeteorologyTin CompoundsTomography, Emission-Computed, Single-PhotonSugar AcidsClick ChemistryFluorineYttrium RadioisotopesTomography, Emission-ComputedFluorine RadioisotopesSodium IodideYtterbiumTechnology, RadiologicModels, TheoreticalOxyquinolineGalliumSolar ActivityTechnetium Tc 99m Aggregated AlbuminCobalt RadioisotopesImino AcidsNuclear Medicine Department, HospitalFluorodeoxyglucose F18Climate ChangeTechnetium Tc 99m Dimercaptosuccinic AcidModels, StatisticalCoordination ComplexesDiphosphatesMeteorological ConceptsTechnetium Tc 99m Mertiatide3-IodobenzylguanidineModels, BiologicalSeasonsTechnetium Tc 99m Sulfur ColloidRadiation MonitoringReceptors, Somatostatinalpha-MethyltyrosineNeuroendocrine TumorsMetabolic Clearance RateTechnetium Tc 99m SestamibiOrganophosphorus CompoundsRainOceanographyChelating AgentsOctreotideRadioimmunotherapyPopulation GrowthIofetamineRadioimmunodetectionUnited States Social Security AdministrationTechnetium Tc 99m ExametazimeEcosystemBone NeoplasmsEncephalitis, St. LouisPopulation DynamicsOximesCitratesOceans and SeasTomography
CAGR2020North AmericaHalf-life of radiopharmaceuticalsSPECTRadiationHealthcare2030NuclearTherapeuticsDynamics20192031SegmentsPeriodSizeWidespreadOncology2018TherapeuticDiagnosis and treatmentRadioactive substancesRadioisotopesEstimates and forecastsGlobalAnalysisNeurologicalMolecular ImagingEurope'sRestraintsTherapyProductMillion diagnostic proceduresIndustryDiagnostic centersCardiacCancer
CAGR22
  • The global nuclear medicine market is projected to reach USD 9.4 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 11.3% during the forecast period. (giiresearch.com)
  • The Global Radiopharmaceutical Market is expected to grow at a CAGR of 8.7% during the forecast period 2017-2023. (medgadget.com)
  • EMAILWIRE.COM, October 03, 2023 ) As per Maximize Market research, the Agricultural Waste Market was USD 16.4 Billion in 2022 and is expected to grow at a CAGR of 7.20 percent over the forecast period to reach USD 28.6 Billion by 2029. (emailwire.com)
  • EMAILWIRE.COM, October 02, 2023 ) As per Maximize Market research, the False Hair Products Market was USD 7.6 Billion in 2022 and is expected to grow at a CAGR of 6.9 percent over the forecast period to reach USD 12.96 Billion by 2029. (emailwire.com)
  • EMAILWIRE.COM, October 02, 2023 ) According to a research report Artificial Intelligence Market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 36.8% during the forecast period, to reach USD 1,345.2 billion by 2030 from USD 150.2 billion in 2023. (emailwire.com)
  • The North American nuclear medicine/radiopharmaceuticals market is poised to reach USD 2.98 Billion by 2020, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020. (prsync.com)
  • EMAILWIRE.COM, June 22, 2017 ) The Latin America Foot and Ankle Devices market has been estimated at USD 0.45 Billion in 2016 and is projected to reach USD 0.65 Billion by 2021, at a CAGR of 7.7% during the forecast period from 2016 to 2021. (emailwire.com)
  • However, Ga68-PSMA is estimated to register the highest CAGR in the market during the forecast period due to factors such as rising prevalence of prostate cancer, technological improvements in diagnosis systems, and its higher sensitivity and accuracy. (itbusinessnet.com)
  • Global Animal Medicine Market Segments And Insights - The animal medicine market size is expected to reach a higher value by 2022, significantly growing at a steady CAGR during the forecast period. (powershow.com)
  • The global Digestive Enzyme Supplements market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 977.9 million by 2025, from USD 794.7 million in 2019. (decisiondatabases.com)
  • Radiopharmaceuticals Market size was valued at USD 6,242.80 million in 2021 and is estimated to reach a compound annual growth rate (CAGR) of 6.2% over the forecast period 2022 to 2029. (marketresearch.com)
  • According to market research study published by Gen Consulting Company, the global radiotherapy, nuclear medicine & radiopharmaceuticals market is expected to reach approximately USD 30,329 million, representing a CAGR of 9.4% during the forecast period 2022-2028. (gen-cons.com)
  • Vantage Market Research analyses that the Radiopharmaceuticals Market is growing with the CAGR of 9.4% in the forecast period of 2023 to 2030 and Radiopharmaceuticals Market size is expected to reach USD 9.75 Billion by 2030. (articlefloor.com)
  • The North American nuclear medicine marke t is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period. (seekingalpha.com)
  • Thus, the market for radiopharmaceuticals is expected to grow at a CAGR of 7.3% during the forecast period of 2021 to 2031. (tmrresearchblog.com)
  • NEWARK, Del, Nov. 20, 2023 (GLOBE NEWSWIRE) - According to the most recent industry data by Future Market Insights, the global antihistamine market was valued at approximately US$ 263.9 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% over the forecast period. (forextv.com)
  • Global USB Charger Market was valued US$31.31 Bn in 2019 and is anticipated to reach US$XX Bn by 2026 at a CAGR of XX % during a forecast. (rewardbloggers.com)
  • The European nuclear medicine/radiopharmaceuticals market is valued at USD 1.095 billion in 2015 and is poised to grow at a CAGR of 8.2% during the forecasted period. (gosreports.com)
  • The global nuclear medicine market size was valued at USD 6.5 billion in 2020 and is anticipated to expand at a CAGR of 9.4% during the forecast period, 2021-2028. (tezbookmarking.com)
  • Hepatic Encephalopathy Treatment Market is rising gradually with a substantial CAGR of 5.4% in the forecast period of 2020-2027. (pharmiweb.com)
  • As per our research report, the global Alzheimer's disease therapeutics and diagnostics market size is forecasted to be growing at a CAGR of 4.67% from 2022 to 2027 and value USD 14844 million by 2027 from USD 11815 million in 2022. (medgadget.com)
  • The global Bluetooth headphones market is projected to expand at a CAGR of 19.2% during the forecast period 2020 to 2026. (uberant.com)
20207
  • The report predicts foreseeable future industry orientation for the forecast total from 2020 to 2030 with the guidance of earlier and present-day market values. (error-page.com)
  • In 2020, the global radiopharmaceuticals market was headed by North America, trailed by Europe. (transparencymarketresearch.com)
  • Due to a rise in PET- CT scanner equipment installations and increased demand for disease risk assessment services for cancer treatment, North America held a large part of the global market for radiopharmaceuticals in 2020. (transparencymarketresearch.com)
  • The report forecasts sales and revenue from 2020 to 2025. (decisiondatabases.com)
  • According to the National Cancer Institute October 2020 data report, researchers have recently designed and tested radiopharmaceuticals for various cancers as diverse as lung, melanoma, colorectal, and leukemia. (marketresearch.com)
  • Also, as per the article published in Nature Reviews Drug Discovery in July 2020, several radiopharmaceutical therapy (RPT) agents are currently on the market, with many more in development. (marketresearch.com)
  • GlobalData forecasts that the total market value of radiopharmaceuticals in oncology will grow from $738 million in 2020 to $3.6 billion by 2026. (bionest.com)
North America6
Half-life of radiopharmaceuticals4
  • However, the short half-life of radiopharmaceuticals decreases their potential adoption, and are expected to challenge market growth to a certain extent. (giiresearch.com)
  • Analysis of key drivers (increasing incidence and prevalence of target conditions, development of alpha-radioimmunotherapy-based targeted cancer treatments, initiatives to reduce the demand and supply gap of Mo-99), restraints (Short half-life of radiopharmaceuticals),opportunities (use of radiopharmaceuticals in neurological applications and high growth opportunities in emerging countries) and challenges (hospital budget cuts and high equipment costs) influencing the growth of nuclear medicine market. (giiresearch.com)
  • However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent. (seekingalpha.com)
  • However, factors such as shorter half-life of radiopharmaceuticals, competition from conventional diagnostic procedures are hindering the growth of this market. (gosreports.com)
SPECT5
  • The diagnostic type radiopharmaceutical segment is further sub-segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. (medgadget.com)
  • The SPECT radiopharmaceutical segment is further sub-segmented into Technetium-99m, Thallium-201, Iodine-123, and others. (medgadget.com)
  • Advancement in the industry has brought about advent of technologies such as PET and SPECT scans which further broadens reach of radiopharmaceuticals. (bharatbook.com)
  • It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. (researchandmarkets.com)
  • The growth of the overall North American nuclear medicine/radiopharmaceuticals market can be contributed to increasing preference for SPECT and PET scans, alpha radio immunotherapy-based targeted cancer treatment, advances in radiotracers, growing incidence of cancer and CVDs, and rising awareness about the effective use of radiopharmaceuticals. (prsync.com)
Radiation8
  • Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. (medgadget.com)
  • Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells. (medgadget.com)
  • The quantity of radiation in diagnostic radiopharmaceuticals is lower than in therapy radiopharmaceuticals. (transparencymarketresearch.com)
  • Some researchers are now testing radiopharmaceuticals combined with radiation sensitizers-drugs that make cancer cells even more vulnerable to radiation. (marketresearch.com)
  • However, the disadvantages of radiopharmaceutical therapy include radiation risks, images that are not usually disease-specific, in this therapy typically requiring injection into the bloodstream, disposal of radioactivity waste and high cost of the treatment. (marketresearch.com)
  • Now, however, interest is rapidly growing in systemically administered radiopharmaceuticals that target radiation directly to cancer cells throughout the body, thus potentially reducing side effects. (bionest.com)
  • The type of scaffold chosen for targeting (i.e. antibodies, antibody fragments, peptides, natural selective accumulation) determines the route by which these radiopharmaceuticals are cleared from the body, their pharmacokinetics, tissue biodistribution, and radiation dosimetry, thus providing a wide range of options for creation of the best therapeutic for a particular cancer type. (bionest.com)
  • Radiopharmaceuticals use targeting agents (small molecules or antibodies) to deliver targeted radiation to cancer cells, regardless of where the cancer is in the body. (medicaex.com)
Healthcare5
  • As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. (medgadget.com)
  • In fact, growth dynamics of healthcare industry overall moves in conjugation with that of radiopharmaceuticals due to its widespread application in various healthcare domains such as cardiology, oncology, neurology, etc. (bharatbook.com)
  • Some of the leading players in the radiopharmaceuticals market include Siemens Healthineers AG, Advanced Accelerator Applications (a Novartis AG Company), GE Healthcare, Jubilant Pharma Limited, ITM Isotopen Technologien München AG, and Bayer AG. (tmrresearchblog.com)
  • This steered to hospitals, clinics, and healthcare laboratories to focus more on the development of nuclear medicine radiopharmaceuticals for the prevention and treatment of diseases and this led to its market growth in the later stages of the COVID-19 pandemic. (tezbookmarking.com)
  • According to a Markets and Markets report, the global AI healthcare sector is forecast to cross the whopping $100 billion mark later this decade. (investorplace.com)
20301
  • Vantage Market Research has published a report on the Global Radiopharmaceuticals Market , which consists of insights about all the vital parameters of the market such as the production and consumption patterns coupled with the revenue patterns for the forecast period 2023-2030. (articlefloor.com)
Nuclear27
Therapeutics5
  • Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which finds applications in clinical areas for diagnostic or therapeutics of human diseases. (bharatbook.com)
  • and Asia Pacific-Japan & China) Outlook 2024" provides information on the current scenario, detailed market outlook of the global radiopharmaceutical market with detailed analysis of market segments such as Diagnostics & Therapeutics. (bharatbook.com)
  • Most recently, Boller was CFO at SOFIE, a molecular diagnostics and therapeutics company in Dulles, Virginia, focused on radiopharmaceuticals. (ansi.org)
  • 1] Furthermore, due to increasing clinical development activity of imaging and therapeutics, the number of patients requiring treatment with radiopharmaceuticals worldwide is set to increase. (medicaex.com)
  • But a string of deals announced in early October, including the purchase of Orchard Therapeutics, may affirm the forecasts of analysts who expect M&A to tick up. (biopharmadive.com)
Dynamics6
  • Entire world PET Radiopharmaceuticals study report addresses the summary PET Radiopharmaceuticals market dynamics, competitive investigation, and top players various approaches to sustain within the entire world market place. (error-page.com)
  • In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. (bharatbook.com)
  • The market research report examines the radiopharmaceutical sector in further depth, offering a comprehensive view of market dynamics, patient preferences, illness trends, and supply and demand. (transparencymarketresearch.com)
  • The report offers insights and in-depth analysis of the market, emphasizing parameters such as dynamics, trends, and opportunities prevailing in the radiopharmaceutical theranostics market. (theinsightpartners.com)
  • In addition, the dynamics of the industry are defined by studying the current and future trends of this Radiopharmaceuticals Industry vertical. (articlefloor.com)
  • Additionally, the complete evolution of the market dynamics along with the supply and demand chain of the product is presented in the Radiopharmaceuticals Market research report. (articlefloor.com)
20191
20312
  • The global radiopharmaceuticals market is estimated to gain a valuation of US$ 8.5 Bn by 2031, notes an assessment by Transparency Market Research (TMR). (tmrresearchblog.com)
  • According to industry analyst reports the market for radiopharmaceuticals is growing rapidly, up 10% year-on-year to US$6 billion in global sales in 2021 and forecast to reach US$33 billion annual sales by 2031. (medicaex.com)
Segments6
  • Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries. (giiresearch.com)
  • Market Research Future published a cooked research report on "Radiopharmaceutical Market Research Report - By Major Industry Trends, Worldwide Business Analysis, Major Segments and Sub segments. (medgadget.com)
  • Future forecasts of radiopharmaceutical market overall and across various sub-segments has been provided till 2024, for all the geographies. (bharatbook.com)
  • For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. (decisiondatabases.com)
  • The study aims at providing granular information, regarding estimates and forecasts for key product segments including contrast reagents, radiopharmaceuticals, and optical imaging reagents. (grandviewresearch.com)
  • Ultimately, the report provides an extensive analysis of the Radiopharmaceuticals Market, highlighting the strategic approaches employed by industry experts and the emergence of new market segments. (articlefloor.com)
Period21
  • Among these, Americas and Europe will continue to present lucrative growth opportunities for market players during the forecast period. (medgadget.com)
  • Due to the substantial availability of competent medical practitioners in hospital radiology departments, the hospital segment is expected to hold a considerable share of this market during the forecast period. (transparencymarketresearch.com)
  • EMAILWIRE.COM, August 22, 2017 ) The Medicated Feed Additives market is showcasing significant potential in the mentioned forecast period. (emailwire.com)
  • However, factors such as strict guidelines for storage, production, and use of radiopharmaceuticals are likely to restrain the growth of the market during the forecast period. (itbusinessnet.com)
  • For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Digestive Enzyme Supplements market. (decisiondatabases.com)
  • The global biologic imaging reagents market is anticipated to grow significantly over the forecast period. (grandviewresearch.com)
  • This market is expected to lead the overall market in terms of share throughout the forecast period. (grandviewresearch.com)
  • The radiopharmaceuticals market holds immense growth opportunities and its market is expected to exhibit a double-digit growth rate during the forecast period. (grandviewresearch.com)
  • However, the Asia-Pacific biologic imaging reagents market will grow at the highest rate during the forecast period. (grandviewresearch.com)
  • The rising prevalence of diseases such as cancer and cardiovascular diseases is expected to boost the market over the forecast period. (marketresearch.com)
  • The diagnostic radiopharmaceuticals segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period. (gen-cons.com)
  • The situation is expected to remain consistent throughout the forecast period owing to the rising air traffic in the region. (thebusinessway.com)
  • The thyroid applications segment is projected to register the highest growth rate in the forecast period. (seekingalpha.com)
  • The report also presents a overall weaknesses which companies operating in the market must avoid in order to enjoy sustainable growth through the course of the forecast period. (ahealthcareindustry.com)
  • It also helps the report provide insights into the opportunities and threats that these companies may face during the forecast period. (ahealthcareindustry.com)
  • What will be the market size by the end of the forecast period? (ahealthcareindustry.com)
  • Thus, such development are likely to introduce new trends in the radioactive tracer market during the forecast period. (business-era.com)
  • As a result of recent advances, the cholinesterase inhibitor medication market is expected to expand over the forecast period. (medgadget.com)
  • Demand for smartphones, laptops, and other smart gadgets will strengthen the Bluetooth headphones market during the forecast period. (uberant.com)
  • The demand for in-ear type in the product type would proliferate the global Bluetooth headphone market in the forecast period. (uberant.com)
  • The Asia Pacific will lead in the regional growth during the forecast period, the growth in the region would be mainly due to the growing demand for smartphones, laptops, and other gadgets. (uberant.com)
Size3
  • The Radiopharmaceuticals Market report provided comprehensive information regarding the driving forces that have a massive impact on the market size. (articlefloor.com)
  • Asia Pacific is expected to hold the largest size of power bank market in a forecast. (rewardbloggers.com)
  • The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. (rewardbloggers.com)
Widespread4
  • In addition, due to their widespread availability and low prices, various radiopharmaceuticals are expected to gain popularity. (transparencymarketresearch.com)
  • The first radiopharmaceutical to enter widespread clinical use was radioactive iodine (I-131), which has been used since the 1940s to treat both hyperthyroidism and malignant thyroid disease. (bionest.com)
  • In May 2013, the alpha-emitter 223 Radium dichloride, developed by Algeta ASA and Bayer Health and marketed as Xofigo®, was approved by the FDA as the first radiopharmaceutical that significantly prolongs survival in castration-resistant prostate cancer patients with widespread bone metastatic disease. (bionest.com)
  • The new machine will enable small and medium sized hospitals to produce their own radiopharmaceutical products in-house, whilst providing more widespread global access to diagnostic solutions in oncology, neurology and cardiology. (business-era.com)
Oncology2
  • The oncology segment is expected to boost the market throughout the forecast. (marketresearch.com)
  • We believe the properties of Bicycles make them well suited for the development of precision guided radiopharmaceuticals and represents the next leg in the application of our proprietary discovery platform in oncology. (biospace.com)
20181
Therapeutic5
Diagnosis and treatment2
Radioactive substances1
  • Radiopharmaceuticals contain radioactive substances used to diagnose or treat diseases, including cancer or cardiology. (marketresearch.com)
Radioisotopes1
Estimates and forecasts2
  • This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. (gen-cons.com)
  • What are the market estimates and forecasts based on which the markets are doing well, and which are not? (micromarketmonitor.com)
Global15
Analysis2
  • Revenue forecast, Company Analysis, Industry landscape, Growth factors … has positively impacted business performances through enhanced … software market report. (inboxrobot.com)
  • In terms of production aspect, the Radiopharmaceuticals Market report provides a complete in-depth analysis regarding the manufacturing processes coupled with the gross earnings gathered by the top manufacturers functioning in this Radiopharmaceuticals Industry. (articlefloor.com)
Neurological1
  • The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. (medgadget.com)
Molecular Imaging1
Europe's1
  • Located in the heart of Belgium's 'Radiopharma Valley', the 2,800 square metre facility is one of Europe's largest radiopharmaceutical production facilities. (medicaex.com)
Restraints1
  • The primary aspect of the Radiopharmaceuticals Market that is covered in the report helps the clients and the organizations to better understand the business profile in terms of drivers, challenges, restraints, and opportunities affecting the market for Radiopharmaceuticals. (articlefloor.com)
Therapy1
  • In 2022 situation is recovering from COVID-19, and the patient can access the proper treatments, leading to market growth of radiopharmaceutical therapy worldwide. (marketresearch.com)
Product2
  • Based on product type, the radiopharmaceutical theranostics market is segmented into positron emission tomography (PET) tracers, beta emitters, and alpha emitters. (theinsightpartners.com)
  • Complete research on the overall development within the market for Radiopharmaceuticals that helps you select the product launch and overtake growth. (articlefloor.com)
Million diagnostic procedures2
Industry2
  • The report separates the marketplace by the greatest company, end-buyers, and their software in line with their a number of info as very well as the industry dimension forecast, consumption, sales profits, cost, financial gain margin, provide and need by location, and customer profile. (error-page.com)
  • Exactly how do the key companies and mid-level companies make income within the Radiopharmaceuticals Industry? (articlefloor.com)
Diagnostic centers1
  • Radiopharmaceuticals are being utilized across hospitals and diagnostic centers. (tmrresearchblog.com)
Cardiac1
Cancer5
  • In the basic design of radiopharmaceutical drugs, a cancer-seeking drug is linked to a radioactive chemical that can actually damage cancer cells via a linker molecule. (fnfresearch.com)
  • Precirix will use the proceeds from the round to complete a phase I/II trial of its lead applicant radiopharmaceutical for the treatment of late-stage breast and gastric cancer. (fnfresearch.com)
  • At ASCO 2021, Novartis presented positive results from the Phase III VISION trial of its lutetium-177-labeled PSMA-617 (prostate-specific membrane antigen) radiopharmaceutical, AAA-617, in progressive PSMA-positive, metastatic, castration-resistant prostate cancer. (bionest.com)
  • Telix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part of its first stage investment of €14.1 million ( $A21.2 million ) Located in Walloon's 'Radiopharma Valley' the facility will be a central hub for research and development for the region and facilitate patient access to this important class of cancer treatment. (medicaex.com)
  • Recent events - including COVID - have taught us that if we are to invest in developing radiopharmaceutical products, we must also invest in ensuring that patients can have access to this new generation of cancer treatments. (medicaex.com)